c225 drug page Clinical trials

Trials with c225

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

1Trials
1Recruiting
1Countries
44Planned patients

Showing 1–1 of 1

Hypofractionated Radiotherapy Combined With NALIRIF, PD-1 Antibody in Locally Recurrent Rectal Cancer(NOVELTY-R)
Recruiting Phase 2 44 patients NCT07183865

This is an open-label, single arm, phase 2 study. The study is to evaluate the activity of combination therapy of hypofractionated radiotherapy, Irinotecan Hydrochloride Liposome plus 5-FU and leucovorin (NALIRIF), Anti-PD1 and target ther…

China Mar 2025 – Mar 2030 Interventional

Where the recruiting trials are